CESTEM-1 clinical trials using dynamin inhibitors to reverse resistance to monoclonal antibody therapy (#16)
Shannon R Joseph
1
,
Katharine Cuff
2
,
Godwins Echejoh
1
,
Hui Yi Chew
1
,
Blerida Banushi
1
,
Brigid King
1
,
Sally Yukiko
1
,
Priscilla De Olivia
1
,
Annabelle Genko
1
,
Alexander Grainger
1
,
Satomi Okano
1
,
Ian H Frazer
1
,
James Wells
1
,
Jermaine Coward
3
4
,
Matthew Foote
5
,
Jennifer Martin
6
,
Ben Panizza
2
3
,
Euan Walpole
2
4
,
Fiona Simpson
1
3
- University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, QLD, Australia
- Faculty of Medicine , University of QLD, Woolloongabba, QLD, Australia
- Queensland Head and Neck Cancer Centre and The Department of Otolaryngology - Head and Neck Surgery, Princess Alexandra Hospital, Woolloongabba, QLD, Australia
- Cancer Services, Department of Oncology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia
- Department of Radiation Oncology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia
- School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia